Company intelligence / Profile preview

LifeTech Scientific

Shenzhen, Guangdong, Chinalifetechmed.com ↗

Ownership: Private
Development stage: Commercial

Overview

LifeTech Scientific has a broad commercial portfolio of minimally invasive interventional medical devices for structural heart and peripheral vascular diseases. The company maintains leading market share in China and has expanded to nearly 120 countries. It holds the world’s first iron-based bioabsorbable material technology platform and continues to invest heavily in R&D with over 2,400 global patent applications as of December 2024. In 2024, revenue exceeded RMB1.3 billion (~$181 million USD).

Therapeutic areas: CardiovascularNeurology
Modalities: Device (minimally invasive interventional medical devices)Iron-based bioabsorbable scaffold
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on LifeTech Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeTech Scientific.

Explore the full profile